BSE - Delayed Quote INR

Ipca Laboratories Limited (IPCALAB.BO)

Compare
1,296.25
-67.70
(-4.96%)
At close: April 9 at 3:29:30 PM GMT+5:30
Currency in INR All numbers in thousands
Download
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
86,433,000
76,224,100
62,068,500
57,664,600
53,660,000
Cost of Revenue
29,061,900
27,257,900
24,075,100
21,059,700
18,017,600
Gross Profit
57,371,100
48,966,200
37,993,400
36,604,900
35,642,400
Operating Expense
45,432,100
39,621,500
30,945,800
25,978,300
22,462,200
Operating Income
11,939,000
9,344,700
7,047,600
10,626,600
13,180,200
Net Non Operating Interest Income Expense
-323,400
-778,200
311,600
229,700
246,800
Pretax Income
10,797,400
8,426,700
7,452,900
11,357,200
13,889,800
Tax Provision
3,550,800
3,134,600
2,533,600
2,247,700
2,401,400
Net Income Common Stockholders
7,294,500
5,473,500
4,713,200
8,840,800
11,400,100
Diluted NI Available to Com Stockholders
7,294,500
5,473,500
4,713,200
8,840,800
11,400,100
Basic EPS
28.74
21.57
18.58
34.85
45.01
Diluted EPS
28.74
21.57
18.58
34.85
45.01
Basic Average Shares
253,771.35
253,704.22
253,704.22
253,704.22
253,279.56
Diluted Average Shares
253,771.35
253,704.22
253,704.22
253,704.22
253,279.56
Rent Expense Supplemental
--
193,000
164,100
154,700
139,900
Total Expenses
74,494,000
66,879,400
55,020,900
47,038,000
40,479,800
Net Income from Continuing & Discontinued Operation
7,294,500
5,473,500
4,713,200
8,840,800
11,400,100
Normalized Income
7,847,588.99
5,809,111.60
4,544,028.73
8,810,882.03
11,478,675.50
Interest Income
--
629,300
793,500
341,700
369,500
Interest Expense
918,100
1,372,900
450,900
72,400
86,100
Net Interest Income
-323,400
-778,200
311,600
229,700
246,800
EBIT
11,715,500
9,799,600
7,903,800
11,429,600
13,975,900
EBITDA
15,673,800
13,372,000
10,519,400
13,753,800
16,067,600
Reconciled Cost of Revenue
29,061,900
27,257,900
24,075,100
21,059,700
18,017,600
Reconciled Depreciation
3,958,300
3,572,400
2,615,600
2,324,200
2,091,700
Net Income from Continuing Operation Net Minority Interest
7,294,500
5,473,500
4,713,200
8,840,800
11,400,100
Total Unusual Items Excluding Goodwill
-824,100
-534,400
256,300
37,300
-95,000
Total Unusual Items
-824,100
-534,400
256,300
37,300
-95,000
Normalized EBITDA
16,497,900
13,906,400
10,263,100
13,716,500
16,162,600
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-271,011.01
-198,788.40
87,128.73
7,382.03
-16,424.50
3/31/2021 - 1/3/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SUNLOC.BO Sunil Healthcare Limited
73.45
+9.79%
 
TYCHE.BO Tyche Industries Limited
138.35
-0.04%
 
GLENMARK.BO Glenmark Pharmaceuticals Limited
1,376.85
-4.32%
 
PANCHSHEEL.BO Panchsheel Organics Limited
148.00
+0.03%
 
NATCAPSUQ.BO Natural Capsules Limited
210.00
+2.39%
 
CORALAB.BO Coral Laboratories Limited
658.65
-1.69%
 
ALKEM.BO Alkem Laboratories Limited
4,837.90
+0.05%
 
BALPHARMA.BO Bal Pharma Limited
104.48
-6.49%
 
INDOCO.NS Indoco Remedies Limited
224.40
-4.97%
 
BAJAJHCARE.BO Bajaj HealthCare Limited
562.90
-3.02%